Johnson & Johnson Inventory, Raw Materials and Supplies, Gross
Johnson & Johnson (JNJ) had Inventory, Raw Materials and Supplies, Gross of $1.35 billion as of 2011-10-02, per its 10-Q filed 2011-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryRawMaterialsAndSupplies · last filed 2011-11-08
- 2011-10-02: Inventory, Raw Materials and Supplies, Gross $1.35B.
- 2011-07-03: Inventory, Raw Materials and Supplies, Gross $1.38B.
- 2011-04-03: Inventory, Raw Materials and Supplies, Gross $1.26B.
- 2011-01-02: Inventory, Raw Materials and Supplies, Gross $1.07B.
| Period end | Inventory, Raw Materials and Supplies, Gross |
|---|---|
| 2011-10-02 | $1.35B 10-Q · filed 2011-11-08 |
| 2011-07-03 | $1.38B 10-Q · filed 2011-08-09 |
| 2011-04-03 | $1.26B 10-Q · filed 2011-05-10 |
| 2011-01-02 | $1.07B 10-Q · filed 2011-11-08 |
| 2010-10-03 | $1.12B 10-Q · filed 2010-11-10 |
| 2010-07-04 | $1.07B 10-Q · filed 2010-08-11 |
| 2010-01-03 | $1.14B 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |